Effect of adding tramadol to Bupivacaine on postoperative pain.

Comparison of the effects of adding tramadol to Bupivacaine on postoperative pain in inguinal hernia surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201010194938N2

Enrollment

Registered

2011-05-30

Start date

2010-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ingunal hernia. Unilateral or unspecified inguinal hernia, without obstruction or gangrene

Interventions

Intervention 1: Group 1

After general anesthesia (sufentanil 10 mcg, midazolam 1 mg , isoflurane o.6% , atracurium) 8 ml bupivacaine 0.25% + 2ml normal salin is injected subfacial in external oblique muscle at the end of sur

Treatment - Other

Group 1

After general anesthesia (sufentanil 10 mcg ,midazolam 1 mg , isoflurane o.6% , atracurium) 8 ml bupivacaine 0.25% + 2ml =100mg tramadol is injected subfacial in external oblique muscle at the end of

After general anesthesia (sufentanil 10 mcg, midazolam 1 mg , isoflurane o.6% , atracurium) 8 ml bupivacaine 0.25% + 2ml normal saline is injected subfacial in external oblique muscle at the end of su

Eligibility

Sex/Gender

All

Age

12 Years to 75 Years

Inclusion criteria

Inclusion criteria: In this study, the candidates for open-elective unilateral inguinal herniorrhaphy with age between 12 & 75 are enrolled if been satisfied. Patients with ASA class more than II, have hernia recurrence, drug addiction, patients with DM (diabetes mellitus), patients who have hypersensitivity to anesthetic drugs and who develope postoperative inflammation or hematoma of surgical site are excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: 2, 4, 8, 12 hourse after suegery. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Level of conscious. Timepoint: 2,4,8,12. Method of measurement: 3 point scale.;The 1th analgesic request. Timepoint: 2,4,8,12. Method of measurement: time report.;Total analgesic intake. Timepoint: 2,4,8,12. Method of measurement: mg.;Nausea & Vomiting. Timepoint: 2,4,8,12. Method of measurement: Observation &Question.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Farzam

Kermanshah university of medical sciences

hfarzam@kums.ac.ir+98 83 1837 6906

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026